Medication info
Samchundang Gliclazide Tablet (Gliclazide)

Samchundang Gliclazide Tablet (Gliclazide)

Prescription medicationTabletOral
Ingredient · strength
Gliclazide›80mg
Manufacturer / importer
(Samchundang Pharmaceuticals Co., Ltd.)
Appearance
White round tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 199100969 · Notified 1991.10.23 · Insurance code 651200610

Summary

Main use
Treatment of type 2 diabetes mellitus when diet and exercise alone are inadequate
Who takes it
Adults
Adult dose
(Tablets)(Capsules) Adults: Start with 40~80mg of gliclazide per day, administered orally in 1~2 doses. Thereafter, to achieve optimal blood glucose control, the dose may be increased up to a maximum of 320mg per day in 2 divided doses, depending on the patient's condition. Do not exceed 160mg per dose. The dose must be adjusted according to the patient's condition. Additional treatment may be required in obese patients or in patients who do not respond adequately to this drug alone. (Extended-release tablets) Adults: Administer 30~120mg of gliclazide orally once daily in the morning, adjusting the dose according to blood glucose levels. If a dose is missed, do not increase the dose the following day. When used in combination with other glucose-lowering agents, the dose should be adjusted according to the individual patient's metabolic response (blood glucose, glycated hemoglobin). * Initial dose The recommended initial dose is 30mg per day. - If blood glucose control is satisfactory, maintain this dose. - If blood glucose control is unsatisfactory, the dose may be increased gradually to 60, 90, and 120mg per day at intervals of at least 1 month. If blood glucose does not decrease after 15 days of treatment, increase the dose from the end of the second week of treatment. Do not exceed the maximum dose of 120mg per day. * Switching from gliclazide 80mg to gliclazide extended-release tablets 30mg: For patients stabilized on gliclazide 80mg, administer according to the principle that "gliclazide 80mg = gliclazide extended-release tablets 30mg." * Switching from another oral glucose-lowering agent to gliclazide extended-release tablets 30mg: Consider the dose and half-life of the previous glucose-lowering agent. In general, switching can be done without any washout period; therefore, start this drug at 30mg per day and gradually increase the dose according to each patient's metabolic response, as described in the "Initial dose" section. For patients switching from a sulfonylurea glucose-lowering agent with a long half-life, a washout period of several days is required to prevent the risk of hypoglycemia due to the additive effects of the two drugs. * Concomitant use with other oral glucose-lowering agents This drug may be used in combination with biguanides, α-glucosidase inhibitors, or insulin. * Patients aged 65 years or older and patients with renal failure This drug may be prescribed using the same dosage regimen as for patients aged 65 years or younger with normal renal function. * Patients at risk of hypoglycemia - Undernourished or malnourished state - Severe or moderate compensated endocrine disorders (anterior pituitary insufficiency, hypothyroidism, corticotropin insufficiency) - Discontinuation of long-term and/or high-dose corticosteroid therapy - Severe vascular disease (severe coronary heart disease, severe carotid artery disease, diffuse vascular disease) → Initiation of treatment at the minimum dose of 30mg per day is recommended.

Ingredients

Manufacturer
(Samchundang Pharmaceuticals Co., Ltd.)

Efficacy & effects

Treatment of type 2 diabetes mellitus when diet and exercise alone are inadequate

  • Type 2 diabetes
View approved original text

This medication is used for patients with type 2 diabetes who find it difficult to control blood sugar levels with diet and exercise alone. It effectively lowers blood sugar levels and contributes to the prevention of complications. Regular use can improve blood sugar control and help maintain a healthy lifestyle.

How to take

Adult dose

(Tablets)(Capsules) Adults: Start with 40~80mg of gliclazide per day, administered orally in 1~2 doses. Thereafter, to achieve optimal blood glucose control, the dose may be increased up to a maximum of 320mg per day in 2 divided doses, depending on the patient's condition. Do not exceed 160mg per dose. The dose must be adjusted according to the patient's condition. Additional treatment may be required in obese patients or in patients who do not respond adequately to this drug alone. (Extended-release tablets) Adults: Administer 30~120mg of gliclazide orally once daily in the morning, adjusting the dose according to blood glucose levels. If a dose is missed, do not increase the dose the following day. When used in combination with other glucose-lowering agents, the dose should be adjusted according to the individual patient's metabolic response (blood glucose, glycated hemoglobin). * Initial dose The recommended initial dose is 30mg per day. - If blood glucose control is satisfactory, maintain this dose. - If blood glucose control is unsatisfactory, the dose may be increased gradually to 60, 90, and 120mg per day at intervals of at least 1 month. If blood glucose does not decrease after 15 days of treatment, increase the dose from the end of the second week of treatment. Do not exceed the maximum dose of 120mg per day. * Switching from gliclazide 80mg to gliclazide extended-release tablets 30mg: For patients stabilized on gliclazide 80mg, administer according to the principle that "gliclazide 80mg = gliclazide extended-release tablets 30mg." * Switching from another oral glucose-lowering agent to gliclazide extended-release tablets 30mg: Consider the dose and half-life of the previous glucose-lowering agent. In general, switching can be done without any washout period; therefore, start this drug at 30mg per day and gradually increase the dose according to each patient's metabolic response, as described in the "Initial dose" section. For patients switching from a sulfonylurea glucose-lowering agent with a long half-life, a washout period of several days is required to prevent the risk of hypoglycemia due to the additive effects of the two drugs. * Concomitant use with other oral glucose-lowering agents This drug may be used in combination with biguanides, α-glucosidase inhibitors, or insulin. * Patients aged 65 years or older and patients with renal failure This drug may be prescribed using the same dosage regimen as for patients aged 65 years or younger with normal renal function. * Patients at risk of hypoglycemia - Undernourished or malnourished state - Severe or moderate compensated endocrine disorders (anterior pituitary insufficiency, hypothyroidism, corticotropin insufficiency) - Discontinuation of long-term and/or high-dose corticosteroid therapy - Severe vascular disease (severe coronary heart disease, severe carotid artery disease, diffuse vascular disease) → Initiation of treatment at the minimum dose of 30mg per day is recommended.

Precautions

This medication is a sulfonylurea that works to lower blood sugar levels. However, caution is required as hypoglycemia may occur when using this medication. Especially, severe hypoglycemia can lead to loss of consciousness, so it is critical to adhere strictly to the dosage and check blood sugar regularly. Symptoms of hypoglycemia may include weakness, headache, tremors, confusion, and visual disturbances; if these symptoms occur, immediate ingestion of sugar is necessary. This medication should not be used by patients with type 1 diabetes, diabetic ketoacidosis, severe liver or kidney impairment, severe infections, or those undergoing surgery, patients with severe gastrointestinal disorders, and individuals allergic to any components of this medication. Additionally, pregnant or nursing women should not take this medication, and elderly patients or those with impaired liver or kidney function should use it cautiously due to a higher risk of hypoglycemia. This medication can interact with other drugs, so it is advised to consult a physician, especially when taken with miconazole, certain anti-inflammatory agents, alcohol, or beta-blockers. During treatment, regular meals, exercise, and self-monitoring of blood sugar are very important, as skipping meals or irregular eating can increase the risk of hypoglycemia. In case of overdose, severe hypoglycemic symptoms may develop, and immediate medical attention is required.

Side effects

Hypoglycemia, weakness, intense hunger, tremors, headache, sensory disturbances, agitation, reduced concentration, aggressiveness, nausea, vomiting, lethargy, sleep disturbances, decreased cognitive function and slow response, depression, confusion, visual and language disorders, aphasia, incomplete paralysis, dizziness, loss of self-control, delirium, shallow breathing, bradycardia, drowsiness, altered consciousness, seizures, sweating, palpitations, cold and damp skin, anxiety, tachycardia, hypertension, angina, deep vein thrombosis, thrombocytopenia, anemia, leukopenia, neutropenia, agranulocytosis, liver dysfunction, hepatitis, jaundice, dyspepsia with vomiting, nausea, abdominal pain, diarrhea, constipation, itching, rash, hives, angioedema, erythema, large blister rash, measles-like papular rash, vesicular reaction, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. This helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White round tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.